Cargando…

Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies

The clinical management of small cell lung cancer (SCLC) treatment remains a major challenge for thoracic oncologists, with very few therapeutic advances significantly impacting patients’ survival. The recent introduction of immunotherapy in the clinical setting produced a marginal benefit for a lim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cani, Massimiliano, Napoli, Valerio Maria, Garbo, Edoardo, Ferrari, Giorgia, Del Rio, Benedetta, Novello, Silvia, Passiglia, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218846/ https://www.ncbi.nlm.nih.gov/pubmed/37240229 http://dx.doi.org/10.3390/ijms24108883

Ejemplares similares

Exploring the Potential of Non-Coding RNAs as Liquid Biopsy Biomarkers for Lung Cancer Screening: A Literature Review
por: Garbo, Edoardo, et al.
Publicado: (2023)

Targeting KRAS in NSCLC: Old Failures and New Options for “Non-G12c” Patients
por: Jacobs, Francesca, et al.
Publicado: (2021)

Exploring the immune-checkpoint inhibitors’ efficacy/tolerability in special non-small cell lung cancer (NSCLC) populations: focus on steroids and autoimmune disease
por: Passiglia, Francesco, et al.
Publicado: (2021)

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients—An Italian Single-Center Experience
por: Persano, Irene, et al.
Publicado: (2023)

Targeting chimeras fusion proteins in non-small cell lung cancer: where are we going?
por: Passiglia, Francesco, et al.
Publicado: (2020)

Should adjuvant treatment be offered to patients with stage IB non-small cell lung cancer?
por: Passiglia, Francesco, et al.
Publicado: (2023)

Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
por: Passiglia, Francesco, et al.
Publicado: (2022)

Is there any place for immune-checkpoint inhibitors in the treatment algorithm of fusion-driven non-small cell lung cancer?—a literature review
por: Leone, Gianmarco, et al.
Publicado: (2020)

Immune-Checkpoint Inhibitors Combinations in Metastatic NSCLC: New Options on the Horizon?
por: Passiglia, Francesco, et al.
Publicado: (2021)

Improving lung cancer outcomes through smoking cessation: the Women Against Lung Cancer in Europe (WALCE) experience
por: Capelletto, Enrica, et al.
Publicado: (2020)

Deciphering Lung Adenocarcinoma Heterogeneity: An Overview of Pathological and Clinical Features of Rare Subtypes
por: Mogavero, Andrea, et al.
Publicado: (2023)

How Does Environmental and Occupational Exposure Contribute to Carcinogenesis in Genitourinary and Lung Cancers?
por: Cani, Massimiliano, et al.
Publicado: (2023)

A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib
por: Malapelle, Umberto, et al.
Publicado: (2022)

Third line scenario in advanced non-small cell lung cancer: is the anti-angiogenetic strategy the only actor up to now?
por: Mecca, Caterina, et al.
Publicado: (2019)

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations
por: Bironzo, Paolo, et al.
Publicado: (2021)

Sarcopenia in heart failure: mechanisms and therapeutic strategies
por: Collamati, Agnese, et al.
Publicado: (2016)

Old and new therapeutic strategies in systemic sclerosis (Review)
por: Bobeica, Carmen, et al.
Publicado: (2022)

Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave
por: Bertaglia, Valentina, et al.
Publicado: (2021)

lncRNA HOTAIR functions and therapeutic perspectives
por: Garbo, Sabrina, et al.
Publicado: (2022)

Immuno-targeted combinations in oncogene-addicted non-small cell lung cancer
por: Listì, Angela, et al.
Publicado: (2019)

Sudden onset acute liver failure in a patient with clinically occult small cell lung carcinoma: autopsy report and review of the medical literature
por: Guerriero, Massimiliano, et al.
Publicado: (2019)

Next RNA Therapeutics: The Mine of Non-Coding
por: Garbo, Sabrina, et al.
Publicado: (2022)

Alectinib in the treatment of ALK-positive non-small cell lung cancer: an update on its properties, efficacy, safety and place in therapy
por: Vavalà, Tiziana, et al.
Publicado: (2018)

Anaplastic lymphoma kinase tyrosine kinase inhibitors in non-small cell lung cancer
por: Vavalà, Tiziana, et al.
Publicado: (2019)

Mitochondria as Therapeutic Targets in Heart Failure
por: Schwemmlein, Julia, et al.
Publicado: (2022)

Therapeutic Strategies for Sleep Apnea in Hypertension and Heart Failure
por: Noda, Akiko, et al.
Publicado: (2013)

Melatonin in Heart Failure: A Promising Therapeutic Strategy?
por: Nduhirabandi, Frederic, et al.
Publicado: (2018)

Metabolic Coupling as a Therapeutic Strategy for Heart Failure
por: Young, Martin E.
Publicado: (2019)

Glucose Metabolism in the Kidney: Neurohormonal Activation and Heart Failure Development
por: Gronda, Edoardo, et al.
Publicado: (2020)

Therapeutic adherence and coping strategies in patients with multiple sclerosis: An observational study
por: Corallo, Francesco, et al.
Publicado: (2019)

Rare thoracic cancers: a comprehensive overview of diagnosis and management of small cell lung cancer, malignant pleural mesothelioma and thymic epithelial tumours
por: Dumoulin, Daphne W., et al.
Publicado: (2023)

Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer
por: Turkaj, Ana, et al.
Publicado: (2018)

ANMCO POSITION PAPER: on administration of type 2 sodium-glucose co-transporter inhibitors to prevent heart failure in diabetic patients and to treat heart failure patients with and without diabetes
por: Gronda, Edoardo, et al.
Publicado: (2021)

Bidirectional Relationship Between Cancer and Heart Failure: Old and New Issues in Cardio-oncology
por: Bertero, Edoardo, et al.
Publicado: (2019)

Second-Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological, and Molecular Aspects of Nintedanib
por: Corrales, Luis, et al.
Publicado: (2017)

COVID-19 and Lung Cancer: A Comprehensive Overview from Outbreak to Recovery
por: Bungaro, Maristella, et al.
Publicado: (2022)

Impact of Plant-Beneficial Bacterial Inocula on the Resident Bacteriome: Current Knowledge and Future Perspectives
por: Vuolo, Francesco, et al.
Publicado: (2022)

Small-molecule sequestration of amyloid-β as a drug discovery strategy for Alzheimer’s disease
por: Heller, Gabriella T., et al.
Publicado: (2020)

RET Fusion-Positive Non-small Cell Lung Cancer: The Evolving Treatment Landscape
por: Novello, Silvia, et al.
Publicado: (2023)

Triple Akt inhibition as a new therapeutic strategy in T-cell acute lymphoblastic leukemia
por: Cani, Alice, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0bkkj246c6nio2tahjils4hmid